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THE EFFECTS OF AEROBIC EXERCISE AND PHYSICAL ACTIVITY ON 
PROGRESSION OF ALZHEIMER’S DISEASE AND MILD COGNITIVE 
IMPAIRMENT  
 
CHAITALI KORGAONKAR 
 
ABSTRACT 
This abstract will provide a brief overview of the following literature review. 
Alzheimer’s disease (AD) is the most common cause of dementia, and is a 
rapidly growing public health concern, as an increasing number of the world’s 
population is living well beyond 65 years of age. Alzheimer’s Disease is a 
progressive neurodegenerative condition, first presenting with mild memory 
impairment, and advancing over the course of years to profound memory loss, 
complete immobility, lack of speech and facial recognition. Currently, only 
palliative treatments are available to delay the progression of the disease, and 
lessen the severity of the cognitive impairment. However, until a cure is available, 
researchers and physicians have turned their attention to alternate therapies, one 
of the most important being exercise. Research efforts have now turned to 
examining the relationship between the positive physiological responses to 
exercise, and attenuation of the classic neurodegenerative patterns in patients 
with AD. The current study examined the effects of aerobic exercise, strength 
training and resistance-based exercise, and multimodal exercise (containing both 
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of the aforementioned exercise modalities) on the physical and mental/cognitive 
health of patients with mild cognitive impairment (MCI) and AD. Thus far, 
exercise therapy has proven to be of great potential value as a supplement to 
pharmacological treatment, as well as a stand-alone prescription for patients with 
a milder form of cognitive impairment due to the onset of a neurodegenerative 
condition. The benefits can be grouped into two categories, cognitive and 
physiological. The effects on cognitive function range from improved memory to 
increased independence in activities of daily living, and the physiological effects 
range from improved clearance of amyloid beta plaques in the brain, to reduction 
of neuroinflammatory processes. The available research on this subject is 
extensive, covering a variety of exercise modalities at different intensities, and 
taking into consideration effects on individuals with MCI, early AD, and advanced 
AD. The general consensus is that continued, long-term adherence to an 
appropriate exercise routine can delay cognitive decline, and help patients with 
neurodegenerative diseases to live independently for a longer period of time. The 
improvements in cognition, memory, immediate recognition, and other related 
cognitive functions are mostly attributed to the heightened health of the brain 
tissue and neural circuitry due to exercise. Exercise (mainly aerobic) enhances 
cerebral blood flow, improves cardiovascular health, reduces the risk for type 2 
diabetes mellitus, and has several other important effects that prevent the 
formation of pathological biomarkers of AD and promote neurogenesis. Atrophy 
of regions such as the hippocampus, amygdala, and cerebral cortex can be 
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prevented, and reversed to a certain extent, as a result of long-term exercise 
therapy. The results of current research could assist physicians and caregivers to 
provide the appropriate type and intensity of exercise to patients with early, 
intermediate, and advanced stages of Alzheimer’s disease. Proactive exercise 
therapy for individuals with a known family history of neurodegenerative disease 
may help to maintain brain volume, specifically in the hippocampus, and reduce 
the risk of severe cognitive impairment. Future directions for research include 
examining the combined effects of pharmacological treatment and exercise 
therapy, and determining the average amount of time by which exercise delays 
the progression of early stage cognitive impairment to advanced impairment.   
 
Key Terms: aerobic exercise, Alzheimer’s disease, amyloid plaque, 
hippocampus, mild cognitive impairment, neurodegeneration, neurofibrillary 
tangle 
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INTRODUCTION 
 
The first part of this thesis will briefly discuss the known impacts of 
Alzheimer’s disease (AD) on cognitive and behavioral functions, significance in a 
public health context, and the importance of diversifying treatment options for 
individuals with early-stage diagnosis. Next, the efficacy of a novel approach to 
mitigating some of the symptoms of Alzheimer’s disease will be discussed 
through a review and analysis of existing literature. This body of literature 
focuses on physical exercise interventions, and their impact on multiple 
parameters used to measure disease progression. Finally, recommendations for 
further study and future directions for research will be given, as well as opinions 
regarding clinical applications of the existing research. 
A brief overview of Alzheimer’s disease   
 Alzheimer’s disease is the most common form of dementia, and is 
currently the sixth leading cause of death in the United States, with over five 
million Americans currently affected by AD. It is a progressive disease affecting 
memory, cognition, and behavior, with advancing age being the most significant 
risk factor (alz.org, 2016). The principal symptoms are decline in short-term 
memory and fine motor skills, speech difficulties, and impairment in mood 
regulation. Ultimately, AD patients may become completely immobile, requiring 
constant care and supervision for activities of daily living (ADL). Early AD is often 
confused with normal age-related change in cognitive ability, and the differences 
between the two are essential in early detection. 
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Table 1. Key differences between Alzheimer’s disease and normal age-
related change. Early detection and diagnosis is the most important way to slow 
the progression of disease symptoms. Taken from (alz.org/10signs (n.d.)).  
 
            
 
 
With a growing aging population, AD is becoming a greater concern in the 
context of public health, as more resources are being used in the care of AD 
patients in assisted living homes, skilled nursing facilities, hospitals, and in their 
own homes. Barnes (2015) estimates that over 20% of United States residents 
are currently over the age of 65 years and approximately 11% of the population 
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over 65 years of age are diagnosed with AD (alz.org, 2016). This impressive 
statistic results from major advances in public health, medical care, accessibility, 
and technology, but also poses a challenge to keep the elderly population in 
good health. Further, individuals who provide care for family members with AD 
often face significant physical, emotional, and financial demands. In 2015, over 
15 million caregivers of AD patients delivered approximately 18.1 billion hours of 
unpaid care, and in 2016, the care of patients with AD and other dementias in the 
United States will cost roughly $236 billion (alz.org, 2016). 
Due to the significant impact of AD on individual families and on the health 
care system, prevention, or delaying the onset of severe symptoms, needs to be 
at the forefront of research efforts. The FDA has approved several 
pharmacological treatments to palliate the symptoms of AD. While none of these 
drugs are curative, they work at various stages of disease progression to 
alleviate some of the most debilitating symptoms, namely, the decline in cognitive 
function. However, the effects of these drugs are limited and transient. 
In the past three to five years, research has expanded to include alternate 
therapies and one that shows promise is physical exercise as a potential 
preventive measure. It has been hypothesized that physical exercise that may 
delay the onset of the more severe symptoms of AD and may improve many of 
the parameters (cognitive function, performance on ADLs, memory recall, and 
histopathological markers such as Aβ deposition and presence of NFTs) that are 
used to measure disease progression.  
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Neuropathological changes in Alzheimer’s disease 
 The hallmark neuropathological signs of AD are protein deposits in the 
brains that include senile plaques and neurofibrillary tangles (Hardy & Allsop, 
1991). The extracellular plaques are made up of amyloid fibrils surrounded by a 
ring of dystrophic neurites, as well as reactive microglia and astrocytes. 
Cleavage of the amyloid precursor protein (APP) by β- secretase and γ-secretase 
yields amyloidogenic Aβ, which is 40 or 42 amino acids in length. Cleavage of 
the protein by α-secretase does not yield the amyloidogenic version. The APP 
gene is located on chromosome 21, and a substitution mutation in the 642nd 
position gives rise to the disease in familial cases inherited through an autosomal 
dominant pattern. A mutation in the 618th position results in cerebral amyloid 
angiopathy and increased risk of cerebral hemorrhage (Hardy & Allsop, 1991). 
However, genetic mutations make up very few cases of AD as compared to the 
sporadic occurrences. Intact APP plays a role in cell-cell adhesion, and aberrant 
cleavage patterns induce the formation of amyloidogenic Aβ (Hardy & Allsop, 
1991).  
 While diffusely staining plaques are common in the cognitively intact 
elderly, plaques with dense cores are found in patients with AD (Serrano-Pozo, 
Frosch, Masliah & Hyman, 2011). The best evidence of Aβ-induced neurotoxicity 
is the presence of dystrophic neurites surrounding the dense core of the plaque. 
Dendrites and axons can become elongated, distorted, or bulbous (Su, 
Cummings & Cotman, 1993). Cytoskeletal abnormalities make these neurons 
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prime candidates for immunoreactive staining techniques. Amyloid plaques 
accumulate mainly in the isocortex, but their spread is not as predictable as that 
of NFTs. The plaques tend to spread to the allocortex, basal ganglia, nuclei of 
the brainstem, and the cerebellum. Similar to NFTs, association areas are 
affected more severely than primary sensory, motor, and visual areas. (Serrano-
Pozo, Frosch, Masliah & Hyman, 2011).  
 There are two staging systems for amyloid deposition. The first system 
progresses through (A) amyloid deposits found in basal portions of the frontal, 
temporal, and occipital lobes, (B) all isocortical association areas affected with 
only mild hippocampal involvement, and (C) deposition of amyloid in primary 
isocortical areas and sometimes in the molecular layer of the cerebellum and 
subcortical nuclei like the striatum, thalamus, hypothalamus, subthalamic 
nucleus, and red nucleus (Braak & Braak, 1991). The second staging system 
consists of (1) isocortical deposition, (2) additional allocortical deposits in the 
entorhinal cortex, hippocampal formation, amygdala, insular, and cingulated 
cortices, (3) involvement of subcortical nuclei including striatum, basal forebrain 
cholinergic nuclei, thalamus, hypothalamus, and white matter, (4) involvement of 
brainstem structures, and (5) amyloid deposits accumulating in the pons and the 
molecular layer of the cerebellum (Thal, Rub, Orantes & Braak, 2002).  
 In addition to accumulating in the brain parenchyma, amyloid plaques also 
build up in the walls of the cerebral vasculature, specifically in the interstitium 
between the smooth muscle cells of the tunica media layer. This is called 
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cerebral amyloid angiopathy (CAA), and can also occur in the absence of AD. 
However, it is very common in AD patients, with about 80% of AD patients 
presenting with CAA at autopsy (Serrano-Pozo, Frosch, Masliah & Hyman, 
2011). The same stains can be used to visualize amyloid plaques in the brain 
parenchyma and in CAA (Congo red, Thioflavin-S, or immunohistochemical stain 
with antibodies against Aβ). The staging system for CAA starts with grade 0, or 
absence of staining; grade 1, congophilic rim around otherwise normal-appearing 
vessel; grade 2, complete replacement of tunica media with congophilic material; 
grade 3, cracking of more than 50% of the vessel circumference, giving a “vessel 
within a vessel” appearance; and grade 4, fibrinoid necrosis of the vessel wall 
with additional amyloid deposit in the surrounding Neuropil (Serrano-Pozo, 
Frosch, Masliah & Hyman, 2011). 
 CAA typically affects cortical capillaries, small arterioles, and middle-sized 
arteries, with little involvement of venules, veins, and white matter arteries. 
Posterior parietal and occipital vasculature is affected more severely than the 
frontal and temporal lobes, but the cause for this is unknown. In the parietal and 
occipital lobes, the leptomeningeal arteries are affected more than the cortical 
arteries. Severity of CAA in a particular region of the cortex is scored from zero to 
four, with a score of zero corresponding to no staining of vasculature, and a 
score of four corresponding to widespread circumferential staining in 
leptomeningeal and cortical vessels, and additional perivascular amyloid 
deposition (Serrano-Pozo, Frosch, Masliah & Hyman, 2011). 
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The dystrophic neurites surrounding amyloid plaques in the brain 
parenchyma contain paired helical filaments, which make up the intracellular 
neurofibrillary tangles (NFTs) consisting of the hyperphosphorylated tau protein 
that is associated with microtubules. Neuropil threads, structures that commonly 
accompany Neuropil threads, are the breakdown products of dendrites and 
axons containing NFTs. The hyperphosphorylation of tau is mediated by the 
neurotoxic properties of Aβ, such as disturbance in calcium homeostasis (Hardy 
& Allsop, 1991).  
There are three morphological stages recognized for NFTs. The first is the 
pre-NFT or diffuse NFT stage that is visualized as diffuse tau staining or 
otherwise normal-looking neurons. Dendrites are intact, and the nucleus is 
centered. The second stage is the mature or fibrillar intraneuronal NFT with 
cytoplasmic filamentous aggregates of tau that push the nucleus off to one side 
of the soma. The proximal portion of the axon, and all dendrites, appear 
distorted. The third stage is extraneuronal ghost NFTs resulting from death of 
neurons with tangles. The nucleus is absent and the cytoplasm stains 
prominently (Braak, Braak & Mandelkow, 1994, Augustinack, Schneider, 
Mandelkow & Hyman, 2002, Su, Cummings & Cotman, 1993). NFTs first appear 
in the allocortex of the medial temporal lobe and spread to the associative 
isocortex. The tangles then accumulate in limbic structures such as the 
hippocampus, amygdala, thalamus, and claustrum. Finally, NFTs spread to all 
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isocortical areas, with associative areas most severely affected (Serrano-Pozo, 
Frosch, Masliah & Hyman, 2011). 
 
Figure 1. Pathological lesions seen in Alzheimer’s disease. (A) Plaque in the 
frontal cortex stained by H&E. (B) Tangle in a hippocampal pyramidal neuron 
stained by H&E. (C) Plaque and a tangle, both highlighted by the silver stain. (D) 
Immunohistochemistry stain against the Aβ plaque. (E) Immunohistochemistry 
stain against the tau tangles. (F) A cortical Lewy body stained by H&E, (panel F 
not from an AD patient). Taken from Serrano-Pozo, Frosch, Masliah & Hyman 
(2011).  
 
 
Common pharmacological treatments for the symptoms of Alzheimer’s 
 Currently, all pharmacological treatments for AD are palliative and only 
treat the symptoms (Table 2). There are no existing drugs that can cure the 
disease completely. Therefore, disease progression can be slowed, but not 
halted. The most widely used treatments are the acetylcholinesterase inhibitors 
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donepezil, rivastigmine, and galantamine (Campos et al., 2016). Figure 2 shows 
the mechanism of action of the cholinesterase inhibitors, specifically at 
cholinergic neurons that innervate the hippocampus. Cholinergic neurons are 
typically lost in the progression of AD (Kim, Moon & Han, 2013), and 
acetylcholine synthesis is therefore diminished. A lack of cholinergic neurons has 
been found to contribute to cognitive deficits in AD patients (Shinotoh et al., 
2000).  
Table 2. Common treatment options for Alzheimer’s disease. Adapted from 
(http://www.alz.org/alzheimers_disease_standard_prescriptions.asp#memantine 
(n.d.)). 
 
Generic Brand Approved For Side Effects 
Donepezil Aricept All stages Nausea, vomiting, 
loss of appetite 
and increased 
frequency of 
bowel movements 
Galantamine Razadyne Mild to moderate Nausea, vomiting, 
loss of appetite, 
and increased 
frequency of 
bowel movements 
Memantine Namenda Moderate to 
severe 
Headache, 
constipation, 
confusion and 
dizziness 
Rivastigmine Exelon Mild to moderate Nausea, vomiting, 
loss of appetite, 
and increased 
frequency of 
bowel movements 
Memantine + 
donepezil 
Namzaric Moderate to 
severe 
Headache, 
diarrhea, 
dizziness, loss of 
appetite, vomiting, 
nausea, and 
bruising 
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Figure 2. Acetylcholinesterase inhibitor: mode of action. Adapted from 
Campos et al. (2016).  
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Another common treatment option is Memantine, an uncompetitive, 
moderate-affinity NMDA receptor antagonist (Campos et al., 2016). The drug 
works based on a voltage-dependent mechanism, such that signal induction is 
blocked when glutamate levels are high. When glutamate levels are high, 
depolarization frequency at the postsynaptic membrane increases, and the 
magnesium ion that blocks the NMDA under basal conditions is displaced. 
Blocking the signal prevents pathological calcium influx and oxidative stress in 
postsynaptic neurons, while physiological levels of signal transmission can still 
occur (Francis, 2009, Danysz, Parsons, Mobius, Stoffler & Quack, 2000, Parsons 
& Gilling, 2007). Memantine essentially decreases extraneous “noise” associated 
with erratic firing and transmission of signals (Francis, 2009). 
 While cholinesterase inhibitors are beneficial for patients with mild to 
moderate AD, memantine is the treatment of choice for patients with moderate to 
severe AD (Campos et al., 2016). Combination therapy with one cholinesterase 
inhibitor along with memantine is another treatment option; however, the efficacy 
and advantage over therapy with just one drug remains inconclusive for patients 
with moderate to severe AD (Campos et al., 2016). Table 2 gives a brief 
summary of the most common treatment options for AD. The multitude of side 
effects from drug therapy makes exercise an appealing alternative for many 
patients and their caregivers.  
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Importance of exercise in Alzheimer’s patients 
 The cognitive and behavioral decline in AD has a great impact on 
cardiorespiratory fitness, which is often a measure of physical fitness that can be 
improved with exercise. This is defined as a measure of the ability of the heart to 
provide the body with oxygenated blood (Yu et al., 2011). With decreased 
cardiorespiratory fitness, there is an increased chance of death at an early age, 
particularly in patients with AD who display neurological and psychological 
symptoms that serve as barriers to promoting physical fitness and adhering to an 
exercise regimen.  
 
Figure 3. Cardiovascular health and relation to neuronal death. Decreased 
cardiorespiratory fitness is almost always seen in patients with cardiovascular 
disease. Both hypertension and hypotension can lead to neuronal death, through 
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lack of blood flow and waste product buildup, as well as Aβ accumulation; 
hypertension may also damage neurons via high pressure flow. Figure adapted 
from Barnes (2015).  
 
 
Boyle et al. (2015) also found an inverse relationship between body mass 
index (BMI) and specific brain volumes, as well as a positive correlation between 
physical activity levels, and whole brain and parietal lobe volume. In patients with 
higher BMI, frontal and occipital lobes in particular had significantly smaller 
regional volumes. Physical activity is clearly a major contributor to good physical 
health, specifically in preserving the brain anatomy as it pertains to patients with 
neurodegenerative diseases. Higher BMI’s can place strain on the cardiovascular 
system, and prevent adequate blood flow from reaching the brain, thus 
increasing the risk of neuronal death and neurodegeneration, as shown in Figure 
4.  
Figures 4, 5, and 6 show the extent of correlation between BMI, physical 
activity, AD or MCI diagnosis and brain volume. Almost the entire brain volume is 
associated with BMI, and smaller portions, specifically the parietal lobe, with 
physical activity alone. Boyle et al. (2015) found well-defined regions 
(orbitofrontal cortex, posterior cingulate gyrus, and posterior hippocampus) that 
were associated with both BMI and physical activity. Weight loss due to aerobic 
exercise and other forms of physical activity can have a great impact on reducing 
brain atrophy and preventing volume loss in specific regions of the brain that are 
also affected by neurodegenerative diseases. Figure 6, from a study by Boyle et 
al. (2015) maps out such brain regions. 
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Figure 4. Correlation of brain volume with BMI and physical activity, brain 
location #1. The top panel shows regions of the brain where volume is 
associated independently with BMI. The center panel shows regions of the brain 
where volume is associated independently with physical activity. The bottom 
panel shows regions of the brain where volume is associated significantly with 
both high BMI and low physical activity. Figure taken from Boyle et al. (2015).  
 
 
Early research on effects of exercise in AD patients focused on the 
feasibility of an exercise program for patients with moderate to severe AD, and 
determining whether cardiorespiratory fitness changed as a result of aerobic 
exercise. Yu et al. (2011) determined that aerobic exercise such as cycling 
indoors was a feasible way to improve cardiorespiratory fitness, and showed that 
with adequate guidance, patients with AD would be able to adhere to such a 
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program. It is recommended that patients with dementia be placed in physical 
exercise (PE) programs in order to maintain cardiovascular and respiratory 
health in spite of declining cognitive function (Ashlskog, Geda, Graff-Radford & 
Petersen, 2011). 
 
 
Figure 5. Correlation of brain volume with BMI and physical activity, brain 
location #2. MRI layout follows same pattern as that described for Figure 3, 
simply examining different brain regions. Figure taken from Boyle et al. (2015).  
 
 
Additionally, ADLs often require strength in the lower extremities, and with 
lack of use, muscle atrophy and weakness perpetuate the inability of AD patients 
to walk, bathe, climb stairs, and stand independently. Assessment of ability to 
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perform ADLs is a key factor in diagnosing dementia, and helps mark the 
progression of many neurodegenerative diseases, including AD (Nascimento et 
al., 2014). With weakness of the extremities, older adults, especially those with 
AD, are not motivated to exercise, and remain sedentary for longer hours in the 
day, thus perpetuating the disease progression (Yu, Savik, Wyman, & Bronas, 
2011, Nascimento et al., 2014). While aerobic exercise proved to increase 
cardiorespiratory fitness, no significant changes were found in lower extremity 
strength, indicating that strength training should also be a focus of research in 
AD patients (Yu, Savik, Wyman & Bronas, 2011). This study also informed the 
idea that various exercise modalities need to be explored, as they improve 
different measures of health and ability to function independently. 
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Figure 6. Correlation of brain volume with BMI and diagnosis of AD or MCI. 
The top panel shows brain regions where volume is significantly correlated with 
BMI. The center panel shows brain regions where volume is significantly 
correlated with positive diagnosis of AD or MCI. The bottom panel shows brain 
regions where volume is significantly correlated with both BMI and positive AD or 
MCI diagnosis. Figure taken from Boyle et al. (2015).  
 
 
Feasibility and safety of exercise in patients with AD 
 One of the main barriers to promoting exercise in the AD patient 
population, in addition to exercise program adherence, is concern for the safety 
of the patient. Without proper balance while using machines, and measures 
taken to ensure security of exercise equipment, there is a great potential for falls 
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and other injuries. However, even mild exercise has the same level of effect on 
cognitive function as moderate exercise, in patients with mild cognitive 
impairment (MCI), which is known as the defining line between normal aging and 
dementia (Varela, Ayán, Cancela & Martín, 2011). Therefore, even simple 
exercises such as walking or light cycling are advantageous, and heavy cycling 
or running exercises are not necessary for positive impacts on health. 
Physiological parameters improved by exercise 
Early small-scale studies that demonstrated the potential success of 
aerobic exercise interventions in improving physical fitness in patients with AD 
opened up possibilities for exercise improving certain parameters more directly 
related to the clinical course of AD. By enhancing blood flow through the brain 
vasculature, neurotrophins such as brain-derived neurotrophic factor (BDNF) and 
glial cell line-derived neurotrophic factor (GDNF) that help to improve neuronal 
plasticity and memory, are up-regulated (Radak et al., 2010, Baker et al., 2010). 
BDNF gene expression is up-regulated by physical activity, and is one of the 
principal determinants of neuronal size and growth (Neeper, Gomez-Pinilla, Choi 
& Cotman, 1996). Additionally, exercise can enhance oxidative stress repair 
mechanisms, thus reducing the chance of free-radical accumulation, which is 
seen even before the characteristic amyloid plaques of AD (Radak et al., 2010, 
García-Mesa et al., 2011). Aerobic exercise can also decrease circulating levels 
of the Aβ biomarker for AD (Baker et al., 2010).  
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Diabetes and pre-diabetes have been consistently proven as risk factors 
for cognitive decline (Ravona-Springer et al., 2010), MCI (Roberts et al., 2008), 
and dementia (Schnaider et al., 2004). Clearance of blood glucose, which has 
also been shown to improve with exercise, is a significant factor in cognitive 
impairment and dementias, as unregulated glucose and insulin levels can have 
adverse impacts on the brain tissue (Baker et al., 2010). Regulation of blood 
glucose levels dictates the efficiency with which numerous metabolic processes 
occur, and also has a direct effect on the metabolism of other fuel sources. 
Promoting exercise in the AD patient population may also work to prevent 
simultaneous diseases such as type 2 diabetes mellitus and associated 
hyperinsulinemia, resulting in further dysregulation of blood glucose. Patients 
with late stages of AD are less likely to be able to manage their own medication 
regimen, and would also be at a higher risk of brain damage or death due to an 
uncontrolled hyper- or hypo-glycemic episode.  
The hippocampus, a structure associated with memory and learning, is 
known to progressively degenerate in AD (Jack et al., 2010), and MRI studies 
show that with exercise, blood flow to the hippocampus increases significantly. 
Increased blood flow may counteract some of the degenerative processes, and 
allow a slower progression of AD (Ashlskog, Geda, Graff-Radford & Petersen, 
2011). Various exercise modalities have been found to affect this parameter in 
different ways. In addition to deterioration of the hippocampus, there is a 
disproportionately large decrease in frontal, parietal, and temporal lobe volumes, 
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which are associated with a broad array of cognitive processes (Park, Polk, 
Mikels, Taylor & Marshuetz, 2001). Deposition of amyloid plaques in both the 
hippocampus and the amygdala is pronounced in patients with MCI and AD 
(Haroutunian et al., 1998, Markesbery et al., 2006), although the hippocampus 
has received more attention in research. 
In many neurodegenerative diseases, sleep disturbances coexist with 
other symptoms, and while the exact cause is unknown, deterioration of the 
hypothalamus and brain stem do affect sleep-wake cycles (Nascimento et al., 
2014). Sleep is often a time of restorative processes in the brain, and sleep 
disturbance prevents the appropriate metabolic processes from taking place in 
the brain tissue. Exercise may improve sleep quality by slowing the progression 
of neurodegenerative diseases (Nascimento et al., 2014). Although there is 
currently no consensus on the best type of PE for Alzheimer’s patients, studies 
have clearly outlined the multiple benefits of various exercise programs (Paillard, 
Rolland & de Souto Barreto, 2015). 
In a broad context, chronic aerobic exercise has been found to improve 
synaptic connections in the brain and improve plasticity (van Praag, Christie, 
Sejnowski & Gage, 1999, Anderson et al., 2000), due to growth of capillaries in 
the brain (Black, Isaacs, Anderson, Alcantara & Greenough, 1990), increased 
length and number of dendritic connections between neurons (Cotman & 
Berchtold, 2002), and increased cell number in the hippocampus (van Praag, 
Christie, Sejnowski & Gage, 1999). All of these effects have significant 
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implications in the progression of AD, and the ability to manipulate such variables 
is advantageous in the treatment of patients with AD. 
 This thesis will explore the direct and indirect benefits of aerobic exercise 
and strength training exercise for AD patients. The effects of various exercise 
modalities on mild cognitive impairment (MCI), a clinical prodrome to dementias 
such as AD will also be discussed. 
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Specific Aims 
The specific aims of this thesis include: 
1. Examination of the effects of aerobic exercise and strength training exercise 
on psychological parameters used to monitor AD progression. 
2. Examination of the effects of aerobic exercise and strength training exercise 
on physiological biomarkers for AD.  
3. Conclude whether or not exercise will help patients with AD. 
4. Provide recommendations for clinicians regarding how to prescribe exercise 
for patients with AD.  
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LITERATURE REVIEW 
 
Studies investigating the neurological and cognitive symptoms of AD 
 This section will explore the effects of various exercise modalities on the 
cognitive function of patients with AD and MCI. Cognitive function includes 
abilities such as memory recall, attention, and executive function, to name a few. 
Although many of the improvements in cognitive function are a result of 
physiological changes in the neural tissue, increased cerebral blood flow, and 
increase in metabolic rate, they will be outlined separately in this section.  
Baker et al. (2010) found that six months of aerobic exercise improved 
executive function, divided attention, cognitive flexibility, and working memory in 
a patient sample with glucose intolerance and risk of cognitive impairment. 
Aerobic exercise resulted in improved glucose handling, and led to improvements 
in the factors listed above, suggesting that the body’s ability to metabolize 
glucose efficiently affects the health and function of neural tissue, leading to 
cognitive function enhancement. These findings not only prove that exercise can 
improve cognitive function, but also underline the interaction between 
physiological (i.e. glucose metabolism) and cognition-related (i.e. attention, 
executive function, memory) benefits of aerobic exercise. 
Suzuki et al. (2013) performed a study, recruiting participants with MCI, 
ages 65 years and older, to complete a multimodal six-month exercise program, 
including aerobic exercise, strength training, postural balance training, and dual-
task training. Using the Alzheimer’s Disease Assessment Scale- cognitive 
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subscale (ADAS-cog), Mini-Mental State Examination (MMSE), and the Wechsler 
Memory Scale (WMS), participants were evaluated for significant changes 
resulting from the exercise regimen, compared to a non-exercise control group. 
Based on the scores for MMSE evaluation, participants with amnestic MCI (MCI 
with memory impairment) showed significant improvement compared to the 
control group. The ADAS-cog and WMS scores showed improvement over six 
months for all MCI exercise participants, compared to the control group. The 
MMSE is typically used to evaluate overall cognitive function, while the ADAS-
cog and WMS are given as more specific tests for memory and executive 
function. These tests give a quantitative measure of the effects of exercise on 
cognitive function, and prove that a multimodal six-month program can benefit 
early stage AD patients, as well as patients with MCI who are at risk for AD 
(Suzuki et al., 2013). 
Smith et al. (2013) conducted a study to determine whether patients with 
MCI who underwent a 12-week walking exercise program (mild aerobic 
exercise), four days a week (30 minutes per session), showed improvement in 
semantic memory fMRI activation, compared to cognitively normal, age-matched 
adults aged 60 to 88 years. Exercise intensity increased throughout the study up 
to 50-60% heart rate reserve. In this study, MCI was defined by multiple 
parameters; the patient had to have concern for his/her changes in memory and 
cognition, the patient had to be impaired in one or more cognitive domains, the 
patient had to be able to perform ADLs independently, and the patient could not 
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be demented (Smith et al., 2013). The fMRI task consisted of 30 celebrity/famous 
names, and 30 names out of a phone book. Participants were later asked to 
match names with either the famous or non-famous list. Although the participants 
with MCI did not experience a significant improvement in the recall and matching 
task, the fMRI showed a decreased volume of tissue activated (based on blood 
flow) post-exercise, in the MCI group and in the cognitively normal group (Smith 
et al., 2013). It may seem paradoxical that the activated tissue volume decreased 
after exercise, but Smith et al. (2011) suggest that this result entails more 
efficient neuronal processing, while greater levels of tissue activation can be 
stressful (Park & Reuter-Lorenz, 2009), and lead to greater brain amyloid 
accumulation, and MCI progression to AD. Smith et al. (2013) suggest that even 
mild exercise improved brain plasticity, resulting in a reduced neural workload, 
which was conveyed in the fMRI results. Reducing stresses on the neuronal 
circuitry is beneficial in delaying the progression from MCI to AD, and can delay 
symptom progression in patients who adhere to a regular exercise regimen, as in 
the abovementioned study.  
Arcoverde et al. (2014) implemented a four-month, controlled treadmill 
exercise regimen for patients diagnosed with AD. A total of 32 treadmill exercise 
sessions were performed at 60% VO2max. Cognitive function was assessed using 
the Cambridge Cognitive Examination (CAMCOG), which includes the Clock 
Drawing Test (executive function) and the verbal fluency test (executive, 
semantic memory and language functions). Additional tests included the Rey 
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Auditory Verbal Learning Test for learning and verbal memory evaluation, and 
the Digit Span test to assess immediate memory and attention. Finally, the Trail 
Making Test was used to evaluate executive function, and the Stroop test 
evaluated selective attention, mental flexibility, and inhibitory control. The results 
of the intervention showed a significant improvement in the exercise group 
compared to the non-exercise control group based on the CAMCOG scores; the 
control group scores actually declined (Arcoverde et al., 2014). However, 
exercise did not correlate with a reduction in scores for the Digit Span and Rey 
Auditory Verbal Learning tests. This study shows that while moderate aerobic 
exercise can improve global cognitive functioning, executive function, semantic 
memory, and verbal/language skills were not improved. 
Progressive memory loss, one of the hallmark features of AD, may be 
delayed via adrenergic agonist administration, which specifically improves 
emotional memory (O’Carroll, Drysdale, Cahill, Shajahan & Ebmeier, 1999, Cahill 
& Alkire, 2003). Exercise has proven to endogenously induce noradrenergic 
activation and emotional memory (McIntyre, Hatfield & McGaugh, 2002, Segal & 
Cahill, 2009). Segal, Cotman & Cahill (2012) note that pharmacological 
administration of noradrenergic agonists could have adverse consequences in 
the elderly, so exercise is a preferred alternate method of activating the system. 
Endogenous norepinephrine production can be measured as salivary alpha-
amylase (sAA) (Segal & Cahill, 2009). In a study by Segal, Cotman & Cahill 
(2012), patients with amnestic MCI (MCI with memory deficit) were recruited to 
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determine the effects of aerobic cycling exercise (at 70% VO2max) on stimulation 
of memory consolidation through activation of the noradrenergic system 
(measured via sAA production). Using scores on image recall tests and 
comparing these with sAA values before and after exercise, it was concluded that 
the exercise group experienced a significant (2-fold) improvement in recall tasks 
compared to control groups. While the study focused only on the effects of acute 
exercise on memory recall, chronic exercise may show even greater benefits in 
memory consolidation through activation of the noradrenergic system. In applying 
these principles to MCI patients, progression to AD can be delayed (Segal, 
Cotman & Cahill, 2012). 
Depending on the type and severity of the dementia, loss of balance is 
commonly associated with MCI and early AD (Allan, Ballard, Burn & Kenny, 
2005, Pettersson, Olsson & Wahlund, 2005, Morgan et al., 2007). Inability to 
maintain balance results in frequent falls, and the inability to perform ADLs 
independently (Sherrington et al., 2008). Task-specific exercises may be most 
beneficial in people with Alzheimer’s disease, since “motor skill transfer” (Toots 
et al., 2016), the ability to use acquired skills in new contexts, is impaired or 
lacking (Dick, Hsieh, Dick-Muehlke, Davis & Cotman, 2000, Dick, Hsieh, Bricker 
& Dick-Muehlke, 2003).  
Toots et al. (2016) studied the effects of exercise on improvement in 
independent performance of ADLs in patients with Alzheimer’s dementia and 
non-Alzheimer’s dementia. The exercises came from the high-intensity functional 
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exercise (HIFE) program developed by Littbrand et al. (2006), and were 
implemented for a four-month period, with five sessions held in each two-week 
time frame. These exercises mimicked the use of muscles in ADLs such as 
standing, rising from a chair, and walking. Balance exercises were implemented 
as part of the intervention, to improve postural stability, according to original 
protocol by Littbrand et al. (2006).  
Toots et al. (2016) found that independence in ADLs worsened in both AD 
dementia and non-AD dementia groups. However, balance improved at the four-
month checkpoint, and then declined at the seven-month checkpoint. The decline 
in balance was most likely due to discontinuation of the exercise after study 
completion. Overall, participants with non-AD dementia experienced better 
outcomes than the AD dementia group, and participants who started with a 
higher baseline cognitive level benefited more from the intervention. The AD 
dementia participants did not experience a significant any improvement in ADL, 
potentially due to difficulties in motor learning that are a symptom of AD (van 
Halteren-van Tilborg, Scherder & Hulstijn, 2007). The motor skill impairment is 
not as pronounced in non-AD dementias such as vascular dementia, underlining 
the added challenges to improving quality of life for patients with AD. This 
intervention did not include any aerobic exercise component, which has had the 
most positive effects on cognition and memory thus far, but has not been tested 
for its ability to improve independent performance on ADLs or balance-related 
tasks. 
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A study by Holthoff et al. (2015) found that a home-based, 12-week 
intervention of passive, motor assisted, or active resistive leg training and 
changes in direction on a movement trainer resulted in a significant improvement 
in independent performance on ADLs in patients diagnosed with AD. At a three-
month follow-up visit, however, the exercise group had returned to baseline 
performance on ADL (same as that prior to the beginning of the intervention 
period). This points to the need for continuity of exercise in order to have long-
term benefit in terms of independence in ADLs. The study by Toots et al. (2016) 
did not use any motorized equipment to augment the training exercises, which 
resulted in a decline in ADLs over time, as is expected with normal AD 
progression. Additionally, Holthoff et al. (2015) implemented the exercise 
regimen in the homes of the participants, allowing for familiarity of surroundings 
to facilitate the participants’ ability to transfer learned leg movements to ADLs. 
The study by Toots et al. (2016) was conducted in specified exercise facilities, 
where the surroundings were not familiar to participants. The impairment of 
“motor skill transfer” in AD patients, as outlined by Toots et al. (2016), was thus 
underlined by the results of these two studies concerning ADLs, by failure to 
improve ADL performance (Toots et al., 2016) and success in improving ADL 
performance (Holthoff et al., 2015). 
The previously mentioned study by Arcoverde et al. (2014) also examined 
the effects of moderate-intensity treadmill exercises on static and dynamic 
balance (using tasks that mimicked ADLs), mobility, lower limb strength, and 
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cardiac rhythms. For all functional capacity tests, the exercise group improved 
significantly, while the control group declined. However, the authors did not 
discuss transferability to real-life and independent performance on ADLs.  
Lu et al. (2016) used a novel intervention type, called momentum-based 
dumbbell training, to assess changes in cognitive function in a sample of patients 
with AD aged 65 years and older, with MMSE scores of 24 or higher. The 
exercises involved arm movements while holding and spinning dumbbells in 
various positions, and focused more on the aspect of strength training. After a 
12-week intervention period (exercise sessions three times per week), the 
training group had significantly improved scores on the ADAS-cog subscale 
compared to the control group, indicating enhanced global cognitive function. 
Scores for the Trail Making Test (for executive function) and Digit Span Test (for 
immediate memory and attention) also showed similar improvements in the 
training group compared to the control group (Lu et al., 2016). This intervention 
was the first of its kind, and demonstrated the advantages of momentum-based 
strength training for patients with AD-related cognitive deficits. Lu et al. (2016) 
did not provide a mechanism by which such exercises improve cognitive 
measures, but positioning and movement of the dumbbells may improve 
spatiotemporal orientation, selective attention, and executive control. The current 
body of literature on strength training and its effects on cognitive function in AD is 
vastly underdeveloped compared to the literature on aerobic exercise, but the 
clear benefits outlined by Lu et al. (2016) give more credibility and push for future 
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strength training studies. 
Studies concerning physiological effects of exercise and biomarkers of AD  
 Proper glucose handling is essential for the energy demands of the body 
(especially the brain), and for ensuring the efficiency of metabolic processes. 
Without the ability to regulate blood glucose, there is an obvious increase in the 
risk of type 2 diabetes mellitus (T2DM), and also a related increased risk of 
cognitive impairment and AD (Baker et al., 2010). The most common intervention 
for T2DM patients is exercise; metabolic disturbances can be reduced in this 
way, and glucose tolerance also improves. Ravona-Springer et al. (2012) 
demonstrate that in non-diabetic elderly subjects with early stages of cognitive 
decline, MMSE scores decreased significantly with increasing HbA1c levels (1.37 
MMSE points per unit HbA1c).  Yaffe, Blackwell, Whitmer, Krueger & Barrett 
(2006) demonstrate that for every 1% increase in HbA1c levels, the likelihood of 
developing MCI and/or dementia increases significantly. Furthermore, high 
HbA1c levels have been correlated with increased risk of cardiovascular disease 
(Park, Barrett-Connor, Wingard, Shan & Edelstein, 1996), which diminishes 
pumping of blood to all vital organs, including the brain, particularly in the 
hippocampus (Mattson, Guthrie & Kater, 1989, Cervos-Navarro & Diemer, 1991). 
Chronically elevated HbA1c levels lead to chronic vascular pathology, which 
results in cognitive decline (Schneider & Bennett, 2010, Duckrow, Beard & 
Brennan, 1987) and may cause MCI to develop into proper dementia. 
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Baker et al. (2010) examined the effects of aerobic exercise in older adults 
with glucose intolerance, on executive control processes. Insulin sensitivity, 
plasma cortisol, BDNF, insulin-like growth factor-1 (IGF-1), and Aβ 1-40 and 1-42 
were also measured.  
A six-month treadmill exercise program by Baker et al. (2010) (4 
days/week) improved glucose handling and cardiorespiratory fitness, decreased 
adiposity and plasma triglyceride levels, and also decreased plasma LDL. Levels 
of AD biomarker Aβ 1-42 (amyloidogenic Aβ peptides) were variable throughout 
the course of the six months, but trended downward overall (Baker et al., 2010). 
According to Moore et al. (2016), Aβ 40 and Aβ 42 show dose-dependent 
decreases in the cortex and hippocampus, with heavy exercise being more 
beneficial than mild exercise, and mild exercise being more beneficial than 
sedentary behavior. This is attributed to improved regulation of glucose; impaired 
regulation alters Aβ metabolism (via degradative enzymes) and results in higher 
frequency of amyloidogenic Aβ formation via enzymatic cleavage by β and/or γ 
secretase (Moore et al., 2016). Aβ degradation enzymes, particularly neprilysin, 
also increased in a dose-dependent manner with mild and heavy exercise, as did 
molecular chaperone proteins (particularly HSP70, but also ApoE, ApoJ, and 
A2M) that facilitated folding of Aβ degradative enzymes (Moore et al., 2016). A 
decrease in soluble cortical Aβ is a positive outcome of exercise in early AD 
patients (Adlard, Perreau, Pop & Cotman, 2005, Um et al., 2011). 
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Cortisol and BDNF increased for the control group and decreased for the 
aerobic exercise group, but these values were not statistically significant in the 
study (Baker et al., 2010). However, Suzuki et al. (2013) found that baseline high 
serum BDNF levels do have a beneficial effect on general cognitive function of 
MCI patients; therefore, while the actual changes in BDNF may be inconsistent, 
the effects of higher serum BDNF are not. Erickson et al. (2011) found that over 
the course of one year, moderate-intensity aerobic exercise did not result in 
greater changes in serum BDNF compared to control groups. However, the same 
study found that in individual participants with greater changes in serum BDNF, 
anterior hippocampal volume increased to a greater extent than in participants 
who did not experience the same amount of change in BDNF. The anterior 
hippocampus is significant in spatial memory (Moser, Moser, Forrest, Andersen 
& Morris, 1995), and shows greater age-related atrophy than the posterior 
hippocampus (Raji, Lopez, Kuller, Carmichael & Becker, 2009). Erickson et al. 
(2011) postulate that areas such as the posterior hippocampus that do not 
degenerate with age, may also be less capable of growth at a later age. Thus, 
the anterior hippocampus is amenable to BDNF-mediated growth in old age, as 
demonstrated by the study conducted by Erickson et al. (2011).  
IGF-1 was not altered by physical activity (Baker et al., 2010). A study by 
Yu, Savik, Wyman, and Bronas (2011) with comparable duration and frequency 
of aerobic exercise in a small sample of patients with AD using a stationary cycle 
showed a significant improvement in cardiorespiratory fitness. Vidoni, Honea, 
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Billinger, Swerdlow & Burns (2012) demonstrated that the improved 
cardiorespiratory fitness significantly slowed brain atrophy and cognitive decline 
in Alzheimer’s patients over the course of two years.  
 Sleep disturbance is yet another problem associated with 
neurodegenerative diseases, including AD, although the exact cause of sleep 
disturbance is unknown (Nascimento et al., 2014). In a study by Nascimento et 
al. (2014), participants with AD who were on regular pharmacological treatment 
were recruited to determine the effects of a multimodal exercise program on 
sleep disturbances. Exercises included a warm up, muscular resistance 
exercises, balance and motor coordination activities, and aerobic exercise. 
Significant reductions in sleep disturbance were observed in the patient sample 
over the course of the six month program (Nascimento et al., 2014). 
Furthermore, performance on ADLs also improved with the multimodal exercise 
program, according to Nascimento et al. (2014), which could be partially 
attributed to decrease in whole brain cortex atrophy in exercising participants 
compared to a control group over a period of six months (Suzuki et al., 2013). 
 A study by Colcombe et al. (2006) compared changes in regional brain 
volumes using high-resolution MRI, between an intervention group that 
participated in six months of cardiovascular exercise, and a control group that 
participated in non-aerobic stretching exercises. All participants were 59 years of 
age or older, and cognitive function was evaluated using the MMSE survey. The 
exercise group started the program at an intensity of 40-50% heart rate reserve, 
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and completed the program at an intensity of 60-70% heart rate reserve. Using 
the MRI scans, maps of the grey and white matter were created, and compared 
pre- and post-intervention. The exercise group showed a greater increase in 
brain volume of grey matter areas compared to the control group in the left 
superior temporal lobe (ISTL), anterior cingulate cortex (ACC)/ supplementary 
motor area (SMA), and right inferior frontal gyrus (rIFG). Additionally, the anterior 
white matter tracts (AWM) also showed significant increases in volume in the 
exercise group compared to the control group (Colcombe et al. 2006). The 
greatest percentage of changes in brain volume occurred in the frontal lobes of 
the brain, where higher order attention control and memory processes take place 
(West, 1996 and Duncan & Owen, 2000, Gunning-Dixon & Raz, 2003). There 
was also an increase in temporal lobe volume, which is significant in the context 
of AD dementia given that the temporal lobe mediates long-term memory, which 
is disrupted in AD (Colcombe et al., 2006). The risk for future volume loss was 
also significantly lower in the same brain regions that experienced increases in 
volume due to physical activity. An additional finding of this study was that the 
peak oxygen uptake (VO2peak) increased significantly by 16.3% in the exercise 
group, while the control participants showed a non-significant 5.3% change 
(Colcombe et al., 2006). This suggests increased oxygen delivery and blood flow 
to the brain, facilitating increased brain volumes. Increased cardiorespiratory 
fitness in patients with early AD has been shown to preserve brain volume, and 
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reduce atrophic processes (Burns et al., 2008), thus slowing disease 
progression.  
 
Figure 7. Increases in brain volumes due to aerobic exercise. Regions of the 
brain showing significant increases in volume in participants who were in the 
aerobic exercise group, compared to those in the non-exercise control group. 
Blue regions show grey matter areas, and yellow regions show white matter 
areas. Image taken from Colcombe et al. (2006).  
 
 
 A study by ten Brinke et al. (2015) also reported significant increases in 
left and right hippocampal volume in aerobic training groups, compared to control 
groups (no exercise) and resistance training groups. It should be noted that this 
study only recruited women of 70-80 years who had probable MCI; the diagnosis 
was not confirmed by specific criteria as in other studies. However, with multiple 
studies reporting increases in hippocampal volume due to exercise, increased 
blood flow, decrease in inflammatory cytokines leading to neuronal atrophy, and 
reduced beta amyloid deposition in the hippocampus all have clear 
neuroprotective effects on this important brain region.  
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 Lin et al. (2015) found that in APP/PS1 transgenic mouse models, 
dendritic arborization improved significantly due to exercise in both the 
hippocampus, specifically in CA1 and CA3 neurons, and in the amygdala. This is 
typically regulated by BDNF signaling pathways (Lin et al., 2012). According to 
the same study, transgenic mice experienced complete restoration of the 
synaptic connections in the amygdala, as visualized by fluorescent dye injection 
into the cytoplasm of individual neurons, which could be at least partially 
attributed to increased levels of BDNF found in the amygdala after a ten-week 
treadmill exercise regimen. Lin et al. (2015) showed that BDNF levels increased 
in the amygdalas of both transgenic and wild type mice, suggesting 
neuroprotective (in wild type) and palliative (in transgenic) effects of exercise. 
The exercise condition significantly reduced the amount of Aβ40 and Aβ42 in the 
amygdala and hippocampus, although the baseline levels in the amygdala were 
highest in the transgenic sedentary (control group) mice (Lin et al., 2015). In the 
same study, low- density lipoprotein receptor-related protein (LRP1) levels 
increased significantly in the hippocampus and amygdala, facilitating better Aβ 
clearance in both regions.  
 In addition to atrophy of certain brain regions, brain inflammation is also 
prevalent in neurodegenerative diseases (Amor, Puentes, Baker & van der Valk, 
2010, McGeer & McGeer, 2010, Faria et al., 2014). Specifically in AD, pro-
inflammatory and anti-inflammatory cytokines are elevated (Brosseron, 
Krauthausen, Kummer & Heneka, 2014), resulting in further neurodegeneration. 
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This occurs due to activation of astrocytes by pro-inflammatory cytokines, 
resulting in the release of more inflammatory cytokines, nitric oxide, and reactive 
oxygen species, all of which accumulate in the neural tissue and cause nerve 
damage (decreased conduction velocity, neuronal shrinkage, and apoptosis) 
(McGeer & McGeer, 2010). Physical activity has been known to decrease 
inflammation in the brain (Souza et al., 2013), and accordingly, Nascimento et al. 
(2014) found that in MCI patients, six months of aerobic exercise (three times per 
week) at 60-80% of heart rate reserve significantly decreased serum levels of 
pro-inflammatory cytokines TNF-α and IL-6. The reduction in pro-inflammatory 
cytokines may serve to depress the rate of neurodegeneration, deriving from the 
strong correlation between inflammation and brain atrophy. However, there 
appears to be a time-dependent effect of exercise on inflammatory cytokines. A 
study by Elahi et al. (2016) found that short term treadmill exercise (five days per 
week for three weeks) resulted in increased neuroinflammation, through 
increases in pro-inflammatory cytokines IL-1β and IL-18. This is due to oxidative 
stress resulting in increased levels of insoluble hyperphosphorylated tau and 
NFTs, further provoking inflammatory processes. Short term exercise, therefore, 
should be avoided, and patients with AD who are started on an aerobic exercise 
regimen should be evaluated for ability to continue exercise over a period of six 
months to one year, optimally.   
 As part of the adaptive immune response, B and T cells are able to enter 
the central nervous system from the periphery to invoke immune (inflammatory) 
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responses, while phagocytic microglial cells within the central nervous system 
contribute most to the innate neuroinflammatory response (Ryan & Nolan, 2016). 
Amyloid plaque and NFT deposition is the major stimulus for inflammation in 
relation to AD pathology (Elahi et al., 2016). When chronically activated, 
microglia have adverse effects on neurons, but other studies have demonstrated 
a role specifically in hippocampal regeneration and neuroprotection upon acute 
bouts of activation (Czeh, Gressens & Kaindl, 2011). Microglia, similar to 
peripheral tissue macrophages, have been categorized into two possible 
polarities in vitro (not yet confirmed in vivo), M1, the pro-inflammatory subtype, 
and M2, the alternatively activated/anti-inflammatory subtype. The cytokine 
milieu in the CSF primarily affects the polarity that is achieved by the microglia 
(Orihuela, McPherson & Harry, 2016). However, as shown by Sierra et al. (2010) 
and Sierra et al. (2014), in the absence of inflammation, microglia provide trophic 
support for newly forming cells, and facilitate apoptosis of nascent cells that do 
not make synaptic connections with existing cells. Currently, the only feasible 
way to predict neurogenesis in human brains is through performance on memory 
tasks. Aerobic exercise, in rodent models, has been shown to promote 
neurogenesis in the hippocampus (Brown et al., 2003), and also reduces pro-
inflammatory cytokine levels (Nascimento et al., 2014), demonstrating the 
increased anti-inflammatory M2 microglial response, which may be beneficial in 
providing support for growing neurons in the hippocampus, and facilitating 
neuronal death if synaptic circuits fail to form (Ryan & Nolan, 2016). With a 
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decrease in neuroinflammation, neurogenesis can occur in limited areas, 
improving performance on memory tasks in both rodent and human models 
(Ryan & Nolan, 2016).   
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DISCUSSION  
There is clear evidence supporting the advantages of both aerobic and 
strength-training exercises in improving psychological parameters used to 
measure the progression of AD. Mild, moderate, and intensive aerobic exercises 
all have beneficial effects on various cognitive functions. An overwhelming 
majority of studies implementing exercise interventions demonstrated that a 
duration of four to six months was an adequate length of time to produce positive 
results. Aerobic exercise has multiple effects including improvements in 
executive function, divided attention, cognitive flexibility, working memory, 
attention, brain plasticity, global cognitive function, semantic memory, recall 
tasks, adrenergic stimulation, balance, and lower limb strength (Suzuki et al., 
2013, Smith et al., 2013, Arcoverde et al., 2014, Segal, Cotman & Cahill, 2012, 
Lu et al., 2016). However, independent performance on ADLs did not improve 
unless the exercise was performed at the home of the participant (Toots et al., 
2016, Holthoff et al., 2015). However, even when the intervention was 
implemented at home, improvements in performance on ADLs were transient, 
returning to baseline after a few months without exercise (Holthoff et al., 2015). 
These findings suggest that exercise should be a continued and long-term 
component of the treatment course for patients with MCI and AD, in order for the 
effects to last. In the studies referred to in this thesis, language and verbal 
function did not improve as a result of moderate aerobic exercise over the course 
of four months (Arcoverde et al., 2014), but more research needs to be done to 
	42 
examine the effects of high intensity exercise and interventions of longer 
duration.  
Strength training mimicking body movements similar to those performed in 
ADLs improved balance transiently, with a return to baseline several months after 
the end of the intervention. The use of motorized devices in aiding body 
movements had a greater impact on the ability to perform ADLs, than did studies 
using a passive approach without the motor-assist (Toots et al., 2016, Holthoff et 
al., 2015). Additionally, home-based strength training interventions were more 
successful in improving ADL performance, as motor skill transfer is impaired in 
patients with AD. Fewer studies have focused on the effects on strength training, 
and more research needs to be done to determine both the feasibility and 
efficacy of strength training on cognitive function and psychological health for 
patients with MCI and patients with AD. To the author’s best knowledge, no 
studies have yet determined the effect of strength training exercise on the 
progression of MCI to early AD.  
Aerobic exercise has many advantageous physiological effects for 
individuals with MCI and AD. Patients with cognitive impairments are at 
increased risk of certain comorbidities, many of which can be prevented with 
regular exercise. Aerobic exercise of any intensity improves cardiorespiratory 
fitness, and decreases the risk of developing cardiovascular disease. 
Additionally, glucose handling is significantly improved with exercise, thus 
decreasing the risk for T2DM (Baker et al., 2010).  
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Aerobic exercise of moderate to high intensity most importantly reduces 
Aβ40 and Aβ42 deposition in the cortex and hippocampus in human subjects, and 
in mouse models, decreases deposition in the hippocampus and amygdala (Lin 
et al, 2015). Long-term aerobic exercise can reduce inflammatory cytokines in 
the CSF, increase Aβ degradative enzymes, and increase grey matter volumes 
by preventing atrophy through increased blood flow to the brain tissue (Moore et 
al., 2016). Short-term exercise over a period of three weeks in mouse models 
was proven to increase oxidative stress and neuroinflammation (Nascimento et 
al., 2014, Elahi et al., 2016); studies in humans will be necessary to validate this 
finding and determine if short bouts of exercise could in fact be harmful.  
In mouse models, aerobic exercise increased hippocampal neurogenesis, 
but this finding has yet to be corroborated in human subjects (Ryan & Nolan, 
2016). If proven true in humans, many cognitive functions associated with the 
hippocampus could be restored or improved, and hippocampal volume 
maintained (ten Brinke et al., 2015). In addition to neurogenesis and increased 
volume, reduced Aβ and NFT deposition in the hippocampus proves that aerobic 
exercise has a tremendous neuroprotective effect on this brain region that is 
adversely affected in AD.  
There are still many gaps in the literature regarding the ways in which 
various types of exercise affect patients with MCI and AD, as well as the 
progression of MCI to AD. The current literature lacks consistency in reporting 
the VO2max achieved during physical activity, as a measure of aerobic exercise 
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intensity. The categories “mild”, “moderate”, and “heavy” are thus difficult to 
quantify. While these values have been defined in literature specific to exercise 
science research, they need to be adapted to elderly patients with 
neurodegenerative disorders. In strength training, intensity is more difficult to 
quantify, and very few studies report physiological effects of strength training or 
resistance-related exercises in patients with MCI or AD. 
Another limitation in this field of research is the inability to easily and 
directly observe changes occurring in the human brain. Mouse models are 
sacrificed post-intervention, and changes in neuronal growth and volume can be 
quantified. However, in human subjects, observations regarding changes to the 
brain anatomy are often inferred based on cognitive functioning tests that are 
targeted to a particular area of the brain, or tests mimicking physiological events 
that cause the release of specific neurotransmitters. Thus, we are limited 
primarily to imaging techniques when studying anatomical changes; imaging 
techniques also have inherent limitations. Post-mortem examination of human 
subjects may occur well after the intervention has ended, and would not provide 
an accurate indication of the effects of the exercise program.  
Many studies, when describing participants, do not specify whether the 
subjects are using pharmacological treatments at the time of the intervention, or 
if they have ever used them prior to the time of the intervention. The interaction 
of drug therapy with an exercise program may have different effects than just 
exercise alone, and such possibilities need to be considered when synthesizing 
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information from multiple studies. Analysis of this body of research with regards 
to coinciding pharmacological treatment must be completed with caution. 
Existing studies that recruited participants with MCI rarely, if ever, 
completed follow-up examinations to determine whether those individuals 
progressed to AD, and if progression was delayed at all by the exercise 
treatment. This information would be useful when prescribing exercise therapy as 
a preventive measure for patients with early signs of cognitive impairment and 
MCI. One final point regarding improvements that need to be made in this field of 
research is regarding the duration of exercise intervention. A vast majority of 
studies implement exercise studies for four to six months. Very few extend study 
time to the span of one year or longer; therefore, long-term exercise effects 
cannot be determined. Participants with MCI or AD who are physically able to 
exercise consistently over the course of several years should be recruited to 
participate in future studies, so that both feasibility and efficacy can be 
determined. 
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CONCLUSION 
 Future research should focus on three main points for improvement: (a) 
exercise intensity should always be reported either through VO2max or heart rate 
reserve; (b) participants taking drug therapy during the exercise intervention 
should be distinguished so that results can be analyzed separately for such 
patients; (c) studies that recruit patients with MCI should follow up after a certain 
time period, or at given time intervals to determine if progression to AD can be 
prevented, or if progression is at least delayed as a result of exercise.  
 With the current research, physicians can still make informed decisions 
regarding exercise prescriptions for patients with early stages of cognitive 
impairment. For patients with MCI, moderate to high intensity aerobic exercise 
can be prescribed to improve brain plasticity and prevent brain atrophy, while 
improving glucose utilization and cardiovascular health. For patients with mild 
AD, at-home, multimodal exercise therapy of moderate intensity can improve 
independent performance on ADLs, and decrease Aβ deposition in important 
brain regions like the hippocampus, cortex, and amygdala. Additionally, when 
exercise is a continued part of preventive therapy, inflammatory and 
degenerative processes in the brain can be slowed and delayed. For patients 
with moderate to severe AD, the tolerated intensity of exercise will vary, and 
physicians prescribe exercise only in supervised settings. Strength training or 
resistance exercises that mimic the movements of ADLs will help provide 
functional skills and prevent inactivity due to inability to stand up, walk, bathe, 
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and move around the home. Patients who can tolerate aerobic exercise should 
be started on a supervised, graded increase in treadmill or cycling exercises. 
 The applications of exercise science are promising in the field of 
neurodegenerative disease. The benefits are multiple and widespread, across 
physiological and psychological arenas. The research on this subject so far has 
built a solid foundation, proving useful for clinical applications, but further 
research needs to be done in order to make well-informed and specific exercise 
prescriptions for patients as a supplement to pharmacological treatments. 
Exercise may also be prescribed for patients with MCI or early stage AD to avoid 
or delay the use of medications. As researchers work towards a pharmacological 
cure for neurodegenerative diseases such as Alzheimer’s disease, exercise 
therapy shows great promise in improving quality of life for the elderly population 
until a cure is found.  
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APPENDIX A 
The following index for establishing a patient’s level of independence in activities 
of daily living was created by Katz, Ford, Moskowitz, Jackson & Jaffe (1963). It is 
commonly used in the clinic and other health care settings to determine 
independence. This index can be further utilized to determine the type of 
exercises an individual should be targeting in order to best improve mobility and 
independence.  
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APPENDIX B 
 
Another scoring scale that is commonly used to determine independence in 
activities of daily living has been established by Lawton & Brody (1969).  
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